Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS SUMMARY: Doubts Raised Over AstraZeneca Virus Jab

Mon, 08th Feb 2021 11:05

(Alliance News) - The following is a summary of top news stories Monday.

----------

COMPANIES

----------

Britons face needing a third jab this year amid concerns about the Oxford University and AstraZeneca vaccine's effectiveness against the South African coronavirus variant. UK Vaccines Minister Nadhim Zahawi was forced to defend the vaccine after a new study in South Africa found it was not effective at preventing mild illness caused by the more infectious mutation. South Africa has suspended the rollout of the British-designed vaccine to healthcare staff following the results, which have yet to be peer reviewed. Zahawi urged the public to keep faith with the Oxford jab as scientists working on the vaccine raised the prospect of having a booster dose available by the autumn. The number of people in the UK who have received a first dose of a vaccine passed the 12 million mark, with jabs administered at a rate of almost 1,000 per minute during a one-hour period over the weekend.

----------

Experian said it is still investigating after recent media reports in Brazil suggested data being sold illegally online might have been sourced from its Serasa business. The London-based credit-checking firm noted "recent media reports" that data, potentially sourced from its Brazilian Serasa unit's non-sensitive marketing data, is being illegally offered for sale online. Experian said it is carrying out a "detailed forensic investigation" into these reports. So far, Experian said it has ascertained that the data for sale "includes photographs, social security INSS, vehicle registrations and social media login details" which its Serasa unit does not hold or collect. Moreover, it said it has seen no evidence of positive or negative credit data being illegally obtained from Serasa, and its "exhaustive investigations" have so far turned up no evidence that its technology systems were compromised.

----------

Arrow Global responded to TDR Capital's fourth potential takeover bid, this time accepted by the financial firm's founder and chief investment officer. TDR, a private equity firm, is offering 305 pence per share in cash, up from its most recent 290p per share offer, which had been rejected by Arrow's board back in January. "The board of Arrow Global is considering the proposal and a further announcement will be made in due course," the company said. The new 305p per share offer is an approximately 67% premium to Arrow's 182.3p average share price for the three months ended Thursday last week, TDR noted, and a 36% premium to its closing price of 224.0p on Thursday. Arrow Global shares added 3.8% on Friday to close at 231.50p and were up 26% at 290.50p each on Monday morning, valuing the company at around GBP515 million.

----------

boohoo Group said it has agreed to buy the Dorothy Perkins, Wallis and Burton brands out of administration for GBP25.2 million. The online-only fashion retailer will be buying the e-commerce and digital assets and associated intellectual property rights, including customer data, related business information and inventory of the Burton, Dorothy Perkins and Wallis brands. The deal does not include any stores. The brands are part of Philip Green's Arcadia Group Ltd, which went under back in November, putting 13,000 jobs at risk. Arcadia's crown jewel, Topshop, was snapped up - along with Topman, Miss Selfridge and HIIT - by ASOS last week.

----------

Drax Group announced its Canadian subsidiary has signed an agreement to acquire Canadian biomass producer and supplier Pinnacle Renewable Energy. The electrical power station operator said deal values Pinnacle's fully diluted equity at CAD385 million, or GBP226 million, with an implied enterprise value of CAD741 million, including net debt of CAD356 million. The acquisition - which is subject to Drax and Pinnacle shareholder, court and regulatory approvals, and the satisfaction of other conditions - has been unanimously recommended by the board of Pinnacle.

----------

MARKETS

----------

Investors in Europe put aside concerns around the Oxford-AstraZeneca vaccine, with investors instead drawing on optimism over a US stimulus package, IG Markets Senior Market Analyst Joshua Mahony noted. US stock market futures were pointing higher, with the S&P 500 called up 0.2% and the Nasdaq Composite up 0.3%. The two benchmarks are set to build on Friday's record close. The Dow Jones Industrial Average is called up 0.3%.

----------

FTSE 100: up 0.8% at 6,538.40

FTSE 250: down 0.1% at 21,043.36

AIM ALL-SHARE: down 0.2% at 1,209.54

GBP: weaker at USD1.3696 (USD1.3728)

EUR: up at USD1.2033 (USD1.2025)

GOLD: higher at USD1,815.13 per ounce (USD1,808.40)

OIL (Brent): higher at USD60.04 a barrel (USD59.62)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

US President Joe Biden anticipates the US rivalry with China will take the form of "extreme competition" rather than conflict between the two world powers. Biden said in an excerpt of a CBS interview aired Sunday that he has not spoken with Chinese counterpart Xi Jinping since he became US president. "He's very tough. He doesn't have – and I don't mean it as a criticism, just the reality – he doesn't have a democratic, small D, bone in his body," Biden said. "I've said to him all along, that we need not have a conflict. But there's going to be extreme competition," Biden said. "I'm not going to do it the way Trump did. We're going to focus on international rules of the road." China is considered in Washington as the US's number one strategic adversary, and the primary challenge on the world stage.

----------

Amazon.com and other internet retail giants could be hit with an online sales tax in a move designed to claw back money the UK owes after heavy borrowing during the pandemic. Treasury sources confirmed Chancellor Rishi Sunak is considering targeting companies that have done well out of the pandemic in order to pay back UK government debts incurred while supporting industries through the coronavirus crisis. The move is being considered as part of a review into business rates following a consultation last year. The Sunday Times reported that leaked emails showed Treasury officials had summoned tech firms and retailers to a meeting this month to discuss how an online sales tax could work.

----------

Irish Foreign Minister Simon Coveney said on Sunday he would be open to an extension of post-Brexit transition period rules for Northern Ireland, the subject of crisis talks between London and Brussels. Coveney told RTE Radio he was "open to advocating for modest extensions of grace periods" but said that scrapping the Northern Ireland Protocol on the movement of goods was out of the question. The Northern Ireland Protocol keeps goods flowing between EU state the Republic of Ireland and Northern Ireland, a part of the UK. The aim is to avoid the creation of a hard border, which could lead to a flare-up in old conflicts. The EU drew international anger last month when it proposed to trigger an emergency clause in the protocol to make controls at the Irish border possible when implementing its new vaccine export register. Following backlash from Dublin, Belfast and London, the EU swiftly backtracked.

----------

Germany's industrial production data painted a mixed picture, with output lagging market estimates monthly in December, but numbers showed a a more moderate year-on-year decline. According to Destatis, industrial production fell 1.0% annually in December, following a 2.5% slide in November. Monthly, output was unchanged, though 0.3% growth was expected, according to market estimates cited by FXStreet. In November, industrial production rose 1.5%. On a calendar-adjusted basis, output in the whole of 2020 was 8.5% lower.

----------

European Central Bank Chief Christine Lagarde on Sunday rejected calls to cancel debts run up by eurozone members to buttress their economies during the Covid-19 crisis. The ECB has taken unprecedented steps to cushion the economic blow from the pandemic in the 19-nation euro area, launching a massive bond-buying scheme that has so far totalled EUR1.85 trillion. "Cancelling that debt is unthinkable," Lagarde told France's Le Journal du Dimanche weekly. "It would be a violation of the European treaty which strictly forbids monetary financing of states," she said, calling it one of the "founding pillars" of the euro single currency. She was reacting to a call on Friday by more than 100 economists for the ECB to further boost the economic recovery of eurozone members by forgiving their debts.

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.